Rejuve Meds Review
Best for: Shoppers wanting transparent, low-cost compounded GLP-1 with no membership fees and HSA/FSA eligibility
Rejuve Meds (Rejuve, Inc.) is a GLP-1 weight-loss telehealth service offering doctor-guided compounded semaglutide at $165/mo and dual-action compounded tirzepatide (GLP-1/GIP) at $265/mo, with no membership fees, free shipping, and HSA/FSA eligibility. Intro pricing starts around $85 for the first month. Medication is fulfilled through its "Rejuve Meds Pharmacy Network"; the individual pharmacies, prescribing medical group, and state-availability list are not named on the marketing site.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Rejuve Meds is a solid telehealth option with balanced features and pricing.
Rejuve Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Dual-action tirzepatide
- Starting price
- $165/mo ($165/mo; intro from $85 first month; $120 summer discount auto-applied; free shipping)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Rejuve Meds
Each dimension is scored algorithmically from Rejuve Meds’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.7/10At $165/mo, Rejuve Meds runs in line with the $169 median for GLP-1 providers.
Effectiveness25%
8.3/10Rejuve Meds offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.6/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.5/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-20).
Accessibility10%
6.7/10Rejuve Meds's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.1/10Rejuve Meds provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Rejuve Meds review
Last checked 2026-06-20- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Rejuve Meds offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
$165/mo; intro from $85 first month; $120 summer discount auto-applied; free shipping
Dual-action GLP-1/GIP compounded formulation; $265/mo
Ready to get started?
Plans and promotions change often — check Rejuve Meds's current pricing and active discounts before you decide.
What we like
- Transparent published pricing: compounded semaglutide $165/mo, tirzepatide $265/mo
- No membership fees — everything is included; free shipping
- HSA/FSA eligible; intro pricing from $85 for the first month
- Doctor-guided programs with personalized care
- Names a "Rejuve Meds Pharmacy Network" for fulfillment
Watch-outs
- Individual compounding pharmacies not named (only a "pharmacy network")
- Prescribing medical group not named
- States of operation not published
- Not LegitScript-certified (no certification displayed)
Is Rejuve Meds worth it? Our verdict
Rejuve Meds positions itself around one thing: Shoppers wanting transparent, low-cost compounded GLP-1 with no membership fees and HSA/FSA eligibility. It runs $165/month.
How much Rejuve Meds actually costs
- Compounded semaglutide — $165/month
- Compounded tirzepatide — $265/month
That's roughly in line with the ~$169/month median across the GLP-1 providers we track.
Medications: what Rejuve Meds prescribes
Rejuve Meds prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who Rejuve Meds is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Rejuve Meds is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
Ready to start with Rejuve Meds?
Starting at $165/month. See current pricing and start your free consultation.
Alternatives to Rejuve Meds
Editorial score · methodology
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Rejuve Meds review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Rejuve Meds?
Starting at $165/month. See current pricing and start your free consultation.